Net revenues (Tables)

9 Months Ended

Oct. 01, 2023

Revenue from Contract with Customer [Abstract]

Schedule of revenue by major customers by reporting segments

The following table disaggregates revenue by global product category for the three and nine months ended October 1, 2023 and September 25, 2022.

	Three Months Ended				Nine Months Ended
	October 1, 2023		September 25, 2022		October 1, 2023		September 25, 2022
Vascular access	$	169,919	$	167,147	$	521,356	$	497,188
Anesthesia	97,612		97,608		291,786		289,260
Interventional	134,089		108,738		375,766		319,939
Surgical	112,805		93,124		317,781		282,468
Interventional urology	73,622		78,969		226,819		233,682
OEM	82,309		71,288		243,434		198,947
Other (1)	76,033		69,914		223,638		211,561
Net revenues (2)	$	746,389	$	686,788	$	2,200,580	$	2,033,045

(1)    Includes revenues generated from sales of our respiratory and urology products (other than interventional urology products).

(2)    The product categories listed above are presented on a global basis, while each of our reportable segments other than the OEM reportable segment are defined based on the geographic location of its operations; the OEM reportable segment operates globally. Each of the geographically based reportable segments includes net revenues from each of the non-OEM product categories listed above.